Sat.Jan 23, 2021 - Fri.Jan 29, 2021

article thumbnail

Digital Health Education for Health Professionals: What are the Next Steps?

The Digital Apothecary

I have served as an academic for the past eight years as an assistant and now associate professor of pharmacy practice, and during this time, my primary concern has been getting health professionals into digital health. It goes without saying it has been an uphill battle, and only in the past 12-24 months have I finally seen significant traction, primarily due to the ongoing Covid-19 Pandemic.

Inpatient 130
article thumbnail

Gene editing: beyond the hype

pharmaphorum

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. ‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because these technologies involve literall

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biden Pledges to Speed Flow of Vaccines to the States

NY Times

President Biden said the amount of coronavirus vaccines reaching the states would rise next week and a deal was near to provide enough shots to vaccinate nearly all Americans by the end of summer.

Vaccines 124
article thumbnail

eCOA tech helps trials tackle COVID-19 obstacles: IQVIA

Outsourcing Pharma

Two leaders from the clinical technology solutions company discuss how digital tools like eCOAs have been invaluable in facing pandemic-related challenges.

119
119
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

PharmaTimes confirms INTCR 2021 virtual finals days

Pharma Times

The 2021 International Clinical Researcher of the Year competition will continue the successes of last year and be conducted virtually.

122
122
article thumbnail

Unlocking health data to improve oncology outcomes

pharmaphorum

As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial health data and real-world evidence (RWE) environment. It’s one that has global potential to improve patient outcomes but efforts to harness the true potential of these information flows are only just beginning. The foundation for this is the NHS’ longstanding commitment to collecting healthcare data.

Hospitals 143

More Trending

article thumbnail

PMN WEBINAR: Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience

Pharma Marketing Network

2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. Some Key Discussion Topics Include: What have we learned about how to create connection within this new paradigm? Which recent innovations are poised to become the best practices that will create measurable impact in 2021? Tune in to listen to the Pharma Marketing Network and leading experts from GSK, Otsuka & Bayer as we navigate these trends and discuss what you need to know to

98
article thumbnail

Researchers identify existing drug’s potential for triple negative breast cancer

Pharma Times

Study suggests that palbociclib could be used to treat around a fifth of people with TNBC

151
151
article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare. There are several important aspects to these shifts for pharma, biotech and medical device companies, so what can we expect to see over the next 12 months and beyond?

article thumbnail

Which Covid Vaccine Should You Get? Experts Weigh the Effect Against Severe Disease

NY Times

Infectious disease doctors say getting a shot of the J&J vaccine, which has a lower efficacy against the virus than other vaccines, would still be well worthwhile.

Vaccines 104
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

PMN WEBINAR: Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience

Pharma Marketing Network

Pharma-Marketing is owned and operated by eHealthcare Solutions. The post PMN WEBINAR: Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience appeared first on Pharma Marketing Network.

97
article thumbnail

Moderna says its COVID-19 vaccine works effectively against variants

Pharma Times

Lab tests evaluated vaccine's efficacy against UK and South African variants

Vaccines 145
article thumbnail

Bad news for Pfizer as blockbuster Xeljanz flunks safety study

pharmaphorum

JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety has achieved the opposite. The post-marketing safety study showed that Xeljanz (tofacitinib) – used to treat rheumatoid arthritis (RA) – was associated with a higher rate of heart attacks and cancer than a TNF inhibitor in patients aged over 50 with underlying cardiovascular risk factors.

Labelling 135
article thumbnail

Veeva Systems converts to a public benefit corporation

Outsourcing Pharma

While the change signifies the life-sciences solutions firmâs commitment to help customers and patients, day-to-day functions will remain much the same.

94
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Portugal?

Drug Patent Watch

This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Portugal? appeared first on DrugPatentWatch - Make Better Decisions.

69
article thumbnail

AZ/Daiichi Sankyo’s antibody drug conjugates prove promising in early trials

Pharma Times

Datopotamab deruxtecan and Enhertu were evaluated in non-small cell lung cancer patients

123
123
article thumbnail

COVID drives a customer experience shift in life sciences CRM

pharmaphorum

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. Gartner’s’ CRM market guide notes that AI, digital scalability and hyper-automation hold the keys to sales success in the post-COVID era, and they highlight the providers who are using digital transformation to find new ways of engaging customers.

article thumbnail

Paradigm4, 54gene collaborate on African clinical data

Outsourcing Pharma

With fewer than 3% of analyzed genomes currently coming from Africans, the companies are looking to increase access to and understanding of patient data.

92
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Vaccine Shortages Hit E.U. in a Setback for Its Immunization Race

NY Times

Spain has suspended vaccinations in Madrid because of a shortfall of doses, as the European Union locks horns with the drugmaker AstraZeneca over vaccine delivery cuts.

article thumbnail

Valneva completes recruitment for Phase I/II COVID-19 vaccine study

Pharma Times

Speciality vaccine company has also started production of vaccine candidate

Vaccines 133
article thumbnail

Clinical research in 2021: A new era of collaboration and innovation

pharmaphorum

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development.

article thumbnail

Survey reveals patients’ thoughts on trial participation

Outsourcing Pharma

Conducted by SubjectWell, the survey of patients with Type 2 diabetes reveals how ethnicity and other factors play a part in trial participation tendencies.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

‘Solidarity Is Failing’: E.U. and U.K. Fight Over Scarce Vaccines

NY Times

As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London are lobbing threats and accusations at each other.

article thumbnail

UK will offer its genomic expertise worldwide to identify new COVID-19 variants

Pharma Times

The New Variant Assessment Platform will be led by Public Health England

131
131
article thumbnail

RedX Pharma CEO focuses on pipeline that found Lilly’s rising star

pharmaphorum

Back in 2017, the UK biotech RedX Pharma had to sell its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for $40 million. That drug, now known as LOXO-305 was one of the stars of the American Society of Haematology (ASH) conference in December, finding its way into Eli Lilly’s pipeline after the big pharma’s $8 billion takeover of Loxo.

Packaging 119
article thumbnail

FDA approves injectable treatment for HIV patients

Outsourcing Pharma

The agency has given the thumbs up to ViiVâs once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.

81
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

If You Squeeze the Coronavirus, Does It Shatter?

NY Times

Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.

article thumbnail

NICE recommends Revlimid for newly diagnosed multiple myeloma patients

Pharma Times

Cost-effectiveness agency initially turned down the drug in this setting

129
129
article thumbnail

Novartis hails digital strategy as profits hold up during pandemic

pharmaphorum

Novartis has said that its investment in digital technology has helped it to ride out the worst of the pandemic, although sales of some of its newly-launched products have been affected by a fall in prescriptions and hospital visits. The big Swiss pharma still managed to grow sales in Q4 compared with the same period last year, with sales increasing a reported 3% to $12.8 billion and profits growing 2% to just over $3 billion.

Hospitals 111
article thumbnail

FDA COVID-19 responses and recommendations this week

Outsourcing Pharma

As the COVID-19 vaccines continue the early stages of circulation in the US, the agency keeps an eye on industry actions and offers advice to key players.

article thumbnail

Which pharmaceutical companies have the most emulsion dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most emulsion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most emulsion dosed drugs…. The post Which pharmaceutical companies have the most emulsion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.